Concepedia

Hitoshi Dejima

HD

22

Publications

1.8K

Citations

17

H-Index

2014

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Teikyo University

Aichi Cancer Center

Nagasaki University

Hitoshi Dejima is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, lung cancer, and immunology.

ORCID

Top concepts

Publications per year

2014–2021

22

Publications

22

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt et al. · Nature Medicine · 2021 · 582 citations · Full text

, , +6

Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer

Hitoshi Dejima, Hisae Iinuma, Rie Kanaoka et al. · Oncology Letters · 2017 · 165 citations · Full text

Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer

Yujin Kudo, Cara Haymaker, J. Zhang et al. · Annals of Oncology · 2019 · 143 citations · Full text

, , +10

Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features

Hitoshi Dejima, Xin Hu, Runzhe Chen et al. · Nature Communications · 2021 · 135 citations · Full text

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

Lorenzo Federico, Daniel J. McGrail, Salah-Eddine Bentebibel et al. · Annals of Oncology · 2021 · 128 citations · Full text

, , +8

Rows per page

1–5 of 22